KCNN2 and ovarian carcinoma: Our results showed for the first time that SK2 is involved in ovarian cancer cell migration and that plasma membrane SK2 plays a key function in LPA‐induced cell migration, suggesting SK2 as potential target that should be inhibited in context of the tertiary prevention after the end of chemotherapy cycles.